Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
Published on 2 months, 4 weeks ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate